4/A: Genelux Corp Director Amends Stock Option Filing Due to Error

A Genelux Corp director amended a previous filing to correct the exercise price of a stock option.

Summary

• A director of Genelux Corp, James L Tyree, filed an amendment to a previous Form 4 filing.
• The amendment corrects a scrivener's error in the original filing regarding the exercise price of a stock option.
• The original filing incorrectly stated the exercise price as $1.54 per share.
• The corrected filing shows the actual exercise price of the stock option is $1.96 per share.
• The stock option was granted on August 1, 2024, and covers 50,469 shares.
• The option vests on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders.
• The option expires on July 31, 2034.

Sentiment

Score: 7

Explanation: The document is a routine correction of a clerical error in a standard SEC filing. It does not indicate any significant positive or negative sentiment.

Negatives

• The original filing contained an error regarding the stock option exercise price, requiring an amendment.

Risks

• Scrivener's errors in SEC filings can lead to confusion and potential compliance issues.

Management Comments

• The reporting person filed a Form 4 which, due to a scrivener's error, incorrectly reported the exercise price of the option to be $1.54 per share.
• In fact, as reported in this amendment, the exercise price of the option is $1.96 per share.

Industry Context

This is a standard SEC filing related to stock options granted to a company director, which is common practice in publicly traded companies.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies, used as a form of compensation and incentive.
• The vesting schedule of the option, tied to the anniversary of the grant date or the next annual meeting, is also a typical arrangement.
• The 10-year expiration period is also a standard term for stock options.

Stakeholder Impact

• The correction ensures accurate information is available to shareholders and the public.

Key Dates

Keywords

Genelux Corp, stock option, Form 4, amendment, director, exercise price, beneficial ownership, SEC filing